Litigation Details for Onyx Therapeutics, Inc. v. Qilu Pharma, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Onyx Therapeutics, Inc. v. Qilu Pharma, Inc. (D. Del. 2016)
| Docket | ⤷ Start Trial | Date Filed | 2016-11-01 |
| Court | District Court, D. Delaware | Date Terminated | 2018-02-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | QILU PHARMACEUTICAL CO., LTD. | ||
| Patents | 7,737,112 | ||
| Attorneys | Jack B. Blumenfeld | ||
| Firms | Smith, Katzenstein, & Jenkins LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Qilu Pharma, Inc.
Details for Onyx Therapeutics, Inc. v. Qilu Pharma, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-01 | External link to document | |||
| 2016-11-01 | 23 | the Commissioner of Patents and Trademarks for Patent/Trademark Number 7,737,112 B2 - 21 [SEALED] STIPULATION…2016 7 February 2018 1:16-cv-01013 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-11-01 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,737,112 B2. (klc) (Entered:…2016 7 February 2018 1:16-cv-01013 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
